Author name: PRNewswire

BD Bilal Muhsin Joins BD as EVP and President of Future Connected Care Segment

BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment

FRANKLIN LAKES, N.J., July 7, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2, Bilal Muhsin has been named executive vice president and will become the president of BD’s future Connected Care segment, as part of the company’s previously announced plans to update

BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment Read Post »

Press
Veris Residential Logo V1

Veris Residential, Inc. Announces Dates for Second Quarter 2025 Financial Results and Webcast

JERSEY CITY, N.J., July 7, 2025 /PRNewswire/ — Veris Residential, Inc. (“Veris Residential” or the “Company”) (NYSE: VRE), a forward-thinking, Northeast-focused, Class A multifamily REIT, today announces that it will host its second quarter 2025 financial results webcast and conference call on Thursday, July 24, 2025 at 8:30 a.m., eastern. The Company will release its results

Veris Residential, Inc. Announces Dates for Second Quarter 2025 Financial Results and Webcast Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. – PETS

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether PetMed and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. – PETS Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BellRing Brands, Inc. – BRBR

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE: BRBR).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether BellRing and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BellRing Brands, Inc. – BRBR Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Designer Brands Inc. – DBI

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Designer Brands Inc.  (“Designer Brands” or the “Company”) (NYSE: DBI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Designer Brands and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Designer Brands Inc. – DBI Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of National Grid plc – NGG

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of National Grid plc (“National Grid” or the “Company”) (NYSE: NGG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether National Grid and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of National Grid plc – NGG Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. – UNCY

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Unicycive and certain of its officers and/or directors have engaged in securities fraud or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. – UNCY Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Centene Corporation – CNC

NEW YORK, July 7, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Centene and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Centene Corporation – CNC Read Post »

Press
Scroll to Top